36966 Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2Commissioner Meredith M. Broadbent 

dissenting. Commissioner Jason E. Kearns did not 

participate in these investigations. 

1The record establishes that Respondent was 

registered as a ‘‘practitioner’’ with respect to each 

of the above DEA registrations. Certifications of 

Registration History for FM5300582 and 

FM5293294, GXs A–1 at 1, 3; A–2, at 1, 3. 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–582 and 731– 

TA–1377 (Final)] 

Ripe Olives From Spain; 

Determinations 

On the basis of the record 1 developed 

in the subject investigations, the United 

States International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to the Tariff Act of 1930 (‘‘the Act’’), 

that an industry in the United States is 

materially injured by reason of imports 

of ripe olives from Spain, provided for 

in subheadings 2005.70.02, 2005.70.04, 

2005.70.50, 2005.70.60, 2005.70.70, and 

2005.70.75 of the Harmonized Tariff 

Schedule of the United States, that have 

been found by the U.S. Department of 

Commerce (‘‘Commerce’’) to be sold in 

the United States at less than fair value 

(‘‘LTFV’’) and to be subsidized by the 

government of Spain.2

Background 

The Commission, pursuant to sections 

705(b) and 735(b) of the Act (19 U.S.C. 

1671d(b) and 19 U.S.C. 1673d(b)), 

instituted these investigations effective 

June 22, 2017, following receipt of a 

petition filed with the Commission and 

Commerce by the Coalition of Fair 

Trade in Ripe Olives, consisting of BellCarter Foods, Walnut Creek, CA, and 

Musco Family Olive Company, Tracy, 

CA. The final phase of the investigations 

was scheduled by the Commission 

following notification of preliminary 

determinations by Commerce that 

imports of ripe olives from Spain were 

subsidized within the meaning of 

section 703(b) of the Act (19 U.S.C. 

1671b(b)) and sold at LTFV within the 

meaning of 733(b) of the Act (19 U.S.C. 

1673b(b)). Notice of the scheduling of 

the final phase of the Commission’s 

investigations and of a public hearing to 

be held in connection therewith was 

given by posting copies of the notice in 

the Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register on 

February 22, 2018 (83 FR 7774). The 

hearing was held in Washington, DC, on 

May 24, 2018, and all persons who 

requested the opportunity were 

permitted to appear in person or by 

counsel. 

The Commission made these 

determinations pursuant to sections 

705(b) and 735(b) of the Act (19 U.S.C. 

1671d(b) and 19 U.S.C. 1673d(b)). It 

completed and filed its determinations 

in these investigations on July 25, 2018. 

The views of the Commission are 

contained in USITC Publication 4805 

(July 2018), entitled Ripe Olives from 

Spain: Investigation Nos. 701–TA–582 

and 731–TA–1377 (Final). 

By order of the Commission. 

Issued: July 25, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–16283 Filed 7–30–18; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Craig S. Morris, DDS; Dismissal of 

Proceeding 

On November 13, 2017, the Acting 

Assistant Administrator, Diversion 

Control Division, Drug Enforcement 

Administration (DEA), issued an Order 

to Show Cause to Craig S. Morris, DDS 

(Respondent), of Texas. The Show 

Cause Order proposed the revocation of 

Respondent’s Certificates of Registration 

FM5300582 and FM5293294 on the 

ground that he ‘‘materially falsified [his] 

applications for [his] DEA Certificates of 

Registration.’’ Order to Show Cause, 

Government Exhibit (GX) A–8 to 

Request for Final Agency Action 

(RFAA), at 1 (citing 21 U.S.C. 824(a)(1)). 

With respect to the Agency’s 

jurisdiction, the Show Cause Order 

alleged that Respondent was registered 

at that time in schedules II through V, 

pursuant to DEA Certificates of 

Registration Nos. FM5300582 and 

FM5293294 at the addresses of 19121 

West Lake Houston Parkway, Humble, 

TX, and 25130 Grogans Park Drive, The 

Woodlands, TX, respectively.1 Id. at 1–2. 

The Order also alleged that these 

registrations would each expire on 

January 31, 2018. Id. 

As substantive grounds for the 

proceeding, the Show Cause Order 

alleged that on February 9, 2015, 

Respondent ‘‘submitted applications to 

the DEA for the above-referenced 

Certificates of Registration’’ but 

materially falsified the application 

when he ‘‘provided a ‘no’ response to 

Liability Question 3, which asked, ‘[h]as 

the applicant ever surrendered (for 

cause) or had a state professional license 

or controlled substances registration 

revoked, suspended, denied, restricted 

or placed on probation, or is any such 

action pending?’ ’’ Id. at 2. The Order 

further alleged that, when he 

‘‘submitted his applications to the DEA 

and provided a ‘no’ answer to Liability 

Question 3, [his] Nevada license to 

practice dentistry had been placed on 

probation and was currently 

suspended.’’ Id. Based on Respondent’s 

alleged ‘‘material falsification of [his] 

applications to the DEA,’’ the Order 

asserted that ‘‘DEA must revoke’’ his 

registrations. Id. at 3. 

The Show Cause Order notified 

Respondent of his right to request a 

hearing on the allegations or to submit 

a written statement in lieu of a hearing, 

the procedure for electing either option, 

and the consequence of failing to elect 

either option. Id. (citing 21 CFR 

1301.43). The Show Cause Order also 

notified Respondent of his right to 

submit a corrective action plan. Id. at 

3–4 (citing 21 U.S.C. 824(c)(2)(C)). 

The Government represents that on 

November 20, 2017, a DEA Diversion 

Investigator (DI) served a copy of the 

Show Cause Order on Respondent by 

electronic mail to an email address that 

the DI had previously used to 

correspond with Respondent in April 

2017 and that Respondent had provided 

to DEA as a ‘‘contact email’’ in 

connection with his DEA Certificates of 

Registration. RFAA, at 3–4 (citing 

Declaration of DI, attached as GX A to 

RFAA, at 3). There is no dispute that 

timely service occurred because the 

Government states that DEA’s Diversion 

Control Division received Respondent’s 

written submissions in connection with 

the Show Cause Order on December 19, 

2017. RFAA, at 4 (citing the Diversion 

Control Division’s Acting Assistant 

Administrator’s December 20, 2017 

letter to Respondent, attached as GX C 

to RFAA, at 1). 

Although Respondent’s submissions 

included a letter (dated December 12, 

2017) entitled ‘‘Corrective Action Plan,’’ 

the letter stated that it was ‘‘being 

submitted in response to the Order to 

Show Cause levied against me by your 

office’’ and attached an affidavit in 

support signed by Respondent and 

notarized on December 15, 2017. 

Respondent’s Written Submissions 

(hereinafter ‘‘Respondent’s Statement’’ 

or ‘‘Resp. Stat.’’), attached as GX B to 

RFAA, at 1. Respondent did not, 

however, request a hearing. See 

generally id. Based on Respondent’s 

submission, I find that he waived his 

right to a hearing on the allegations. 21 

CFR 1301.43(c). However, pursuant to 

21 CFR 1301.43(c), I deem Respondent’s 

submission to be his ‘‘written statement 


daltland on DSKBBV9HB2PROD with NOTICES